The PRISMA 2020 statement: An updated guideline for reporting systematic reviews,International Journal of Surgery

当前位置： X-MOL 学术 › Int. J. Surg. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
International Journal of Surgery ( IF 12.5 ) Pub Date : 2021-03-29 , DOI: 10.1016/j.ijsu.2021.105906
Matthew J Page ₁ , Joanne E McKenzie ₁ , Patrick M Bossuyt ₂ , Isabelle Boutron ₃ , Tammy C Hoffmann ₄ , Cynthia D Mulrow ₅ , Larissa Shamseer ₆ , Jennifer M Tetzlaff ₇ , Elie A Akl ₈ , Sue E Brennan ₁ , Roger Chou ₉ , Julie Glanville ₁₀ , Jeremy M Grimshaw ₁₁ , Asbjørn Hróbjartsson ₁₂ , Manoj M Lalu ₁₃ , Tianjing Li ₁₄ , Elizabeth W Loder ₁₅ , Evan Mayo-Wilson ₁₆ , Steve McDonald ₁ , Luke A McGuinness ₁₇ , Lesley A Stewart ₁₈ , James Thomas ₁₉ , Andrea C Tricco ₂₀ , Vivian A Welch ₂₁ , Penny Whiting ₁₇ , David Moher ₂₂

Affiliation

School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, Netherlands.
Université de Paris, Centre of Epidemiology and Statistics (CRESS), Inserm, F 75004, Paris, France.
Institute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Australia.
University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; Annals of Internal Medicine, USA.
Knowledge Translation Program, Li Ka Shing Knowledge Institute, Toronto, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Evidence Partners, Ottawa, Canada.
Clinical Research Institute, American University of Beirut, Beirut, Lebanon; Department of Health Research Methods, Evidence, And Impact, McMaster University, Hamilton, Ontario, Canada.
Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR, USA.
York Health Economics Consortium (YHEC Ltd), University of York, York, UK.
Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada; Department of Medicine, University of Ottawa, Ottawa, Canada.
Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, JB Winsløwsvej 9b, 3(rd) Floor, 5000, Odense, Denmark; Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark.
Department of Anesthesiology and Pain Medicine, The Ottawa Hospital, Ottawa, Canada; Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Canada; Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Department of Ophthalmology, School of Medicine, University of Colorado Denver, Denver, CO, United States; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Division of Headache, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Head of Research, The BMJ, London, UK.
Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, Bloomington, IN, USA.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Centre for Reviews and Dissemination, University of York, York, UK.
EPPI-Centre, UCL Social Research Institute, University College London, London, UK.
Li Ka Shing Knowledge Institute of St. Michael's Hospital, Unity Health Toronto, Toronto, Canada; Epidemiology Division of the Dalla Lana School of Public Health and the Institute of Health Management, Policy, And Evaluation, University of Toronto, Toronto, Canada; Queen's Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, Canada.
Methods Centre, Bruyère Research Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.

The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.

中文翻译：

PRISMA 2020 声明：更新的系统评价报告指南

系统评价和元分析的首选报告项目 (PRISMA) 声明于 2009 年发布，旨在帮助系统评价者透明地报告为什么进行评价、作者做了什么以及他们发现了什么。在过去十年中，系统评价方法和术语的进步使得指南需要更新。PRISMA 2020 声明取代了 2009 年声明，并包括新的报告指南，反映了识别、选择、评估和综合研究方法的进步。项目的结构和呈现方式已被修改以促进实施。在本文中，我们介绍了 PRISMA 2020 27 项清单、详细说明每个项目的报告建议的扩展清单、PRISMA 2020 摘要清单、

更新日期：2021-03-29

点击分享查看原文

点击收藏

阅读更多本刊新发论文本刊介绍/投稿指南